{"protocolSection":{"identificationModule":{"nctId":"NCT00984308","nctIdAliases":["NCT00807417"],"orgStudyIdInfo":{"id":"IIR 06-233"},"organization":{"fullName":"VA Office of Research and Development","class":"FED"},"briefTitle":"Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease","officialTitle":"Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease","acronym":"Go To Sleep"},"statusModule":{"statusVerifiedDate":"2017-05","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2008-12-23","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2011-09-30","type":"ACTUAL"},"completionDateStruct":{"date":"2011-09-30","type":"ACTUAL"},"studyFirstSubmitDate":"2009-09-24","studyFirstSubmitQcDate":"2009-09-24","studyFirstPostDateStruct":{"date":"2009-09-25","type":"ESTIMATED"},"resultsFirstSubmitDate":"2015-03-31","resultsFirstSubmitQcDate":"2015-08-10","resultsFirstPostDateStruct":{"date":"2015-09-01","type":"ESTIMATED"},"lastUpdateSubmitDate":"2017-05-15","lastUpdatePostDateStruct":{"date":"2017-06-14","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"VA Office of Research and Development","class":"FED"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false,"isUsExport":false},"descriptionModule":{"briefSummary":"Sleep apnea is common among Veterans with cerebrovascular disease (stroke or transient ischemic attack \\[TIA\\]), leads to hypertension, and is associated with recurrent stroke and death. Although continuous positive airway pressure (CPAP) safely treats sleep apnea, few Veterans with cerebrovascular disease are diagnosed with sleep apnea or offered treatment.","detailedDescription":"The project sought to evaluate whether a diagnostic and therapeutic intervention strategy among Veterans with cerebrovascular disease and hypertension using unattended polysomnography and auto-titrating CPAP with a targeted adherence evaluation and educational protocol resulted in: an improved rate of diagnosed sleep apnea, an improved rate of treated sleep apnea, and improved blood pressure control."},"conditionsModule":{"conditions":["Obstructive Sleep Apnea","Stroke","Transient Ischemic Attack","Hypertension"],"keywords":["sleep apnea","hypertension","brain ischemia"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2","PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":225,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Intervention","type":"EXPERIMENTAL","description":"The intervention group received unattended polysomnography and auto-titrating CPAP if sleep apnea was diagnosed","interventionNames":["Procedure: CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA)"]},{"label":"Control","type":"OTHER","description":"The control group received usual clinical care which may include receipt of sleep diagnostic and therapeutic services","interventionNames":["Procedure: CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA)"]}],"interventions":[{"type":"PROCEDURE","name":"CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA)","description":"Continuous Positive Airway Pressure (CPAP) is provided for those patients who are diagnosed with OSA.","armGroupLabels":["Control","Intervention"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Sleep Apnea Diagnosis Rate","description":"The number of patients with a diagnosis of sleep apnea","timeFrame":"The entire study period (baseline and up to one-year)"},{"measure":"Hypertension Control","description":"Medication-Adjusted Systolic Blood Pressure","timeFrame":"One year"}],"secondaryOutcomes":[{"measure":"Sleep Apnea Treatment Rate","timeFrame":"One year"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nStroke or Transient Ischemic Attack Hypertension\n\nExclusion Criteria:\n\n* Prior diagnosis of sleep apnea or other sleep disorder\n* Life expectancy \\< 6 months or Hospice\n* Non-English speaker\n* Unable/unwilling to use mask\n* Inability to give informed consent\n* Oxygen dependent COPD\n* Chronic renal failure with dialysis\n* Active Suicidal Ideation","healthyVolunteers":false,"sex":"ALL","minimumAge":"40 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Dawn M. Bravata, MD","affiliation":"Richard L. Roudebush VA Medical Center, Indianapolis, IN","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"VA Connecticut Healthcare System West Haven Campus, West Haven, CT","city":"West Haven","state":"Connecticut","zip":"06516","country":"United States","geoPoint":{"lat":41.27065,"lon":-72.94705}},{"facility":"Richard L. Roudebush VA Medical Center, Indianapolis, IN","city":"Indianapolis","state":"Indiana","zip":"46202-2884","country":"United States","geoPoint":{"lat":39.76838,"lon":-86.15804}}]},"referencesModule":{"references":[{"pmid":"22179539","type":"BACKGROUND","citation":"Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 3;125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046. Epub 2011 Dec 15. No abstract available. Erratum In: Circulation. 2012 Jun 5;125(22):e1002."},{"pmid":"23283859","type":"BACKGROUND","citation":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 1;127(1):143-52. doi: 10.1161/CIR.0b013e318282ab8f. No abstract available."},{"pmid":"23239837","type":"BACKGROUND","citation":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 1;127(1):e6-e245. doi: 10.1161/CIR.0b013e31828124ad. Epub 2012 Dec 12. No abstract available. Erratum In: Circulation. 2013 Jan 1;127(1):doi:10.1161/CIR.0b013e31828124ad. Circulation. 2013 Jun 11;127(23):e841."},{"pmid":"21885958","type":"RESULT","citation":"Sico JJ, Phipps MS, Yaggi HK, Burrus N, Ferguson J, McClain V, Austin C, Li X, Bravata DM. Ambulatory blood pressure monitoring among patients with cerebrovascular disease. Blood Press Monit. 2011 Oct;16(5):211-7. doi: 10.1097/MBP.0b013e32834b4d6c."},{"pmid":"22334806","type":"RESULT","citation":"Bravata DM, Ferguson J, Miech EJ, Agarwal R, McClain V, Austin C, Struve F, Foresman B, Li X, Wang Z, Williams LS, Dallas MI, Couch CD, Sico J, Fragoso C, Matthias MS, Chumbler N, Myers J, Burrus N, Dube A, French DD, Schmid AA, Concato J, Yaggi HK. Diagnosis and Treatment of Sleep Apnea in patients' homes: the rationale and methods of the \"GoToSleep\" randomized-controlled trial. J Clin Sleep Med. 2012 Feb 15;8(1):27-35. doi: 10.5664/jcsm.1654."},{"pmid":"24458967","type":"RESULT","citation":"Schmid AA, Yaggi HK, Burrus N, McClain V, Austin C, Ferguson J, Fragoso C, Sico JJ, Miech EJ, Matthias MS, Williams LS, Bravata DM. Circumstances and consequences of falls among people with chronic stroke. J Rehabil Res Dev. 2013;50(9):1277-86. doi: 10.1682/JRRD.2012.11.0215."},{"pmid":"22968110","type":"RESULT","citation":"Zis P, Spengos K, Manios E, Vemmos K, Zis V, Dimopoulos MA, Zakopoulos N. Ambulatory blood pressure monitoring in acute stroke: the importance of time rate of blood pressure variation. Blood Press Monit. 2012 Oct;17(5):220-1; author reply 221-2. doi: 10.1097/MBP.0b013e3283588e8a. No abstract available."}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Intervention","description":"The intervention group received unattended polysomnography and auto-titrating CPAP if sleep apnea was diagnosed"},{"id":"FG001","title":"Control","description":"The control group received usual clinical care which may include receipt of sleep diagnostic and therapeutic services"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"110"},{"groupId":"FG001","numSubjects":"115"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"92"},{"groupId":"FG001","numSubjects":"109"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"18"},{"groupId":"FG001","numSubjects":"6"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Intervention"},{"id":"BG001","title":"Control"},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"110"},{"groupId":"BG001","value":"115"},{"groupId":"BG002","value":"225"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"69.7","spread":"10.4"},{"groupId":"BG001","value":"70.2","spread":"10.1"},{"groupId":"BG002","value":"70","spread":"10"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"6"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"109"},{"groupId":"BG001","value":"110"},{"groupId":"BG002","value":"219"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Sleep Apnea Diagnosis Rate","description":"The number of patients with a diagnosis of sleep apnea","populationDescription":"The intervention patients had polysomnography at baseline (n=102) whereas control patients either had polysomnography as part of usual care (n=7) or at the end of the study as part of the study protocol (n=85). The n=7 patients who had polysomnography as part of usual care were included in the analysis for this outcome.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"The entire study period (baseline and up to one-year)","groups":[{"id":"OG000","title":"Intervention"},{"id":"OG001","title":"Control"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"102"},{"groupId":"OG001","value":"7"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"5"}]}]}]},{"type":"PRIMARY","title":"Hypertension Control","description":"Medication-Adjusted Systolic Blood Pressure","populationDescription":"ITT","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"mm Hg","timeFrame":"One year","groups":[{"id":"OG000","title":"Intervention"},{"id":"OG001","title":"Control"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"110"},{"groupId":"OG001","value":"115"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"157.4","spread":"25"},{"groupId":"OG001","value":"161.6","spread":"24.3"}]}]}]},{"type":"SECONDARY","title":"Sleep Apnea Treatment Rate","populationDescription":"Among the 58 intervention patients with a diagnosis of sleep apnea, CPAP data were available for 57. Among the 7 control patients who received polysomnography as part of usual care, 5 had sleep apnea: CPAP data were available for 4 patients (2 did not receive any CPAP and 2 had CPAP therapy), the data card was unavailable for 1 patient.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"One year","groups":[{"id":"OG000","title":"Intervention"},{"id":"OG001","title":"Control"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"2"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"0"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","eventGroups":[{"id":"EG000","title":"Intervention","seriousNumAffected":5,"seriousNumAtRisk":110,"otherNumAffected":22,"otherNumAtRisk":110},{"id":"EG001","title":"Control","seriousNumAffected":2,"seriousNumAtRisk":115,"otherNumAffected":30,"otherNumAtRisk":115}],"seriousEvents":[{"term":"stroke","organSystem":"Nervous system disorders","notes":"new stroke event in patient with history of cerebrovascular disease","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":115}]},{"term":"Transient ischemic attack (TIA)","organSystem":"Nervous system disorders","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":115}]},{"term":"Congestive heart failure (CHF)","organSystem":"Cardiac disorders","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":110},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":115}]},{"term":"Acute myocardial infarction (AMI)","organSystem":"Cardiac disorders","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":115}]},{"term":"DEATH","organSystem":"General disorders","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":115}]}],"otherEvents":[{"term":"Falls","organSystem":"General disorders","stats":[{"groupId":"EG000","numEvents":22,"numAffected":22,"numAtRisk":110},{"groupId":"EG001","numEvents":30,"numAffected":30,"numAtRisk":115}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":true},"pointOfContact":{"title":"Dawn M. Bravata, MD","organization":"Department of Veterans Affairs","email":"dawn.bravata2@va.gov","phone":"317-988-2676"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001049","term":"Apnea"},{"id":"D000012891","term":"Sleep Apnea Syndromes"},{"id":"D000020181","term":"Sleep Apnea, Obstructive"},{"id":"D000002546","term":"Ischemic Attack, Transient"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000006973","term":"Hypertension"}],"ancestors":[{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000012120","term":"Respiration Disorders"},{"id":"D000012140","term":"Respiratory Tract Diseases"},{"id":"D000012818","term":"Signs and Symptoms, Respiratory"},{"id":"D000020919","term":"Sleep Disorders, Intrinsic"},{"id":"D000020920","term":"Dyssomnias"},{"id":"D000012893","term":"Sleep Wake Disorders"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M9714","name":"Hypertension","asFound":"Hypertension","relevance":"HIGH"},{"id":"M4051","name":"Apnea","asFound":"Apnea","relevance":"HIGH"},{"id":"M15384","name":"Sleep Apnea Syndromes","asFound":"Sleep Apnea","relevance":"HIGH"},{"id":"M21700","name":"Sleep Apnea, Obstructive","asFound":"Obstructive Sleep Apnea","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M5485","name":"Ischemic Attack, Transient","asFound":"Transient Ischemic Attack","relevance":"HIGH"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","asFound":"Cerebrovascular Disease","relevance":"HIGH"},{"id":"M16045","name":"Syndrome","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M14647","name":"Respiration Disorders","relevance":"LOW"},{"id":"M14667","name":"Respiratory Tract Diseases","relevance":"LOW"},{"id":"M15313","name":"Signs and Symptoms, Respiratory","relevance":"LOW"},{"id":"M21932","name":"Parasomnias","relevance":"LOW"},{"id":"M22344","name":"Sleep Disorders, Intrinsic","relevance":"LOW"},{"id":"M22345","name":"Dyssomnias","relevance":"LOW"},{"id":"M15386","name":"Sleep Wake Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC08","name":"Respiratory Tract (Lung and Bronchial) Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"}]}},"hasResults":true}